Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2000
12/21/2000CA2376467A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000CA2376217A1 Novel formulations comprising lipid-regulating agents
12/21/2000CA2376067A1 Use of paclitaxel and steroid derivatives as aromatase inhibitors for the treatment of cancer
12/21/2000CA2375155A1 Protein localization assays for toxicity and antidotes thereto
12/21/2000CA2374909A1 Human intracellular signaling molecules
12/21/2000CA2374555A1 Thiol derivative, metallo-beta-lactamase inhibitors
12/21/2000CA2340663A1 Antiviral indoleoxoacetyl piperazine derivatives
12/20/2000EP1060750A2 Method for treating amyloidosis
12/20/2000EP1060741A1 Sustained release microspheres
12/20/2000EP1060254A2 Human proteinase molecules
12/20/2000EP1060251A2 Phosphodiesterase 10
12/20/2000EP1060174A1 Nitric oxide releasing chelating agents and their therapeutic use
12/20/2000EP1059943A1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
12/20/2000EP1059941A1 Pharmaceutical compositions and their use
12/20/2000EP1059940A2 Method for treating painful conditions of the anal region and compositions therefor
12/20/2000EP1059939A1 Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue
12/20/2000EP1059938A1 Photothermal structure for biomedical applications, and method therefor
12/20/2000EP1059930A1 Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
12/20/2000EP1059923A1 Combination of a selective nmda nr2b antagonist and an opioid analgesic
12/20/2000EP1059919A1 Small molecules that increase the conversion of food to body weight gain
12/20/2000EP1059917A1 Anti-asthma therapy
12/20/2000EP1059889A1 Treatment of brain edema using carbonic anhydrase enzyme inhibitor
12/20/2000EP1059883A1 Integrated poration, harvesting and analysis device, and method therefor
12/20/2000EP1059882A1 Integrated tissue poration, fluid harvesting and analysis device, and method therefor
12/20/2000EP1059843A1 Method for decreasing qt dispersion or inhibiting the progression of qt dispersion with an angiotensin ii receptor antagonist
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000EP0788352B1 Treatment of animals
12/20/2000EP0714295B1 Fibrinogen receptor antagonists
12/20/2000CN1277634A New tissue-specific calpaines, their production and their use
12/20/2000CN1277556A Application of TNF antagonists as medicaments for treating septic diseases
12/20/2000CN1277550A Modified release multiple-units compositions of non-steroid anti-inflammatory drug sbstances (NSAIDS)
12/20/2000CN1277549A Vesicular complexes and methods of making and using the same
12/19/2000US6162827 Treatment of negative and cognitive symptoms of schizophrenia with D-serine
12/19/2000US6162818 Respiratory system disorders; crohn's disorder; cardiovascular disorders
12/19/2000US6162815 Hyperglycemia
12/19/2000US6162805 Use of an NK-1 receptor antagonist and an SSRI for treating obesity
12/19/2000US6162792 Use of spiramycin for treating gastrointestinal disorders caused by H. pylori
12/19/2000US6162618 Nucleotide sequence; recombinant production; diagnosis of infections; drug screening; bactericides; bacteriostats; enzyme inhibitors; vaccines
12/19/2000US6162600 Indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
12/19/2000US6162431 Serine/threonine protein kinase
12/19/2000US6162427 Treating tumor by administering colony stimulating factor
12/19/2000US6161544 Methods for accelerated orthokeratology
12/19/2000CA2174658C Novel composition
12/19/2000CA2050291C Combination therapy for the treatment of estrogen sensitive diseases
12/19/2000CA2028629C Antiandrogenically-effective pharmaceutical compositions
12/14/2000WO2000075365A2 Compounds and methods to enhance raav transduction
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075328A1 Human sel-10 polypeptides and polynucleotides that encode them
12/14/2000WO2000075323A1 Tek antagonists
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075317A2 Compositions and methods for the treatment of tumor
12/14/2000WO2000075311A1 Recombinant nematode nicotinic receptor and uses
12/14/2000WO2000075305A2 Candida albicans genes and proteins coded by said genes
12/14/2000WO2000075191A2 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM
12/14/2000WO2000075187A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000WO2000075121A2 Process for preparing 10,11-methanobenzosuberane derivatives
12/14/2000WO2000074933A1 Composite laminate and method for its production
12/14/2000WO2000074784A1 Combination for treating weight gain associated with antipsychotic use comprising an atypical antipsychotic and an h2 antagonist
12/14/2000WO2000074745A1 Drug releasing elastic band and method
12/14/2000WO2000074742A1 Devices and compounds for treating arterial restenosis
12/14/2000WO2000074729A2 Alpha or beta emitters to fragments in radioimmunotherapy
12/14/2000WO2000074725A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000WO2000074721A1 Vitamin directed dual targeting therapy
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074688A1 Methods for preventing formation of inhibitory antibodies in the setting of gene therapy
12/14/2000WO2000074687A1 Antisense modulation of b7 protein expression
12/14/2000WO2000074686A1 Modulators of methylation for control of bacterial virulence
12/14/2000WO2000074677A2 Improved pharmaceutical formulations
12/14/2000WO2000074675A1 Antilipemic combinations comprising hmg-coa reductase inhibitors and carnitines
12/14/2000WO2000074667A2 Compositions active in telomere damage comprising a taxane and telomerase inhibitor
12/14/2000WO2000074666A2 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia
12/14/2000WO2000074662A2 Arthritis treatment
12/14/2000WO2000074654A1 Novel preparation and administration form comprising an acid-labile active compound
12/14/2000WO2000074653A1 Oil-core compositions for the sustained release of hydrophobic drugs
12/14/2000WO2000074652A1 Pharmaceutical composition for nasally administering water-soluble active substances
12/14/2000WO2000074651A1 Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water
12/14/2000WO2000074634A2 Methods and compositions for modulating cell proliferation and cell death
12/14/2000WO2000074584A1 Devices and methods for treating tissue
12/14/2000WO2000074500A1 Compositions containing creatine in suspension
12/14/2000WO2000074489A1 Stable biocidal compositions
12/14/2000WO2000057190A3 Prediction of diabetes impaired wound healing
12/14/2000WO2000054049A3 Determination of the chemosensitivity via the caspase activity
12/14/2000WO2000053776A3 Human kallikrein-like genes
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000047284A3 Novel use of orexin receptor antagonists
12/14/2000WO2000047231A3 Novel antisense inhibition of rad51
12/14/2000WO2000047229A3 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
12/14/2000WO2000045770A3 Compressed lecithin preparations
12/14/2000WO2000044763A3 Compositions for treating inflammatory response
12/14/2000WO2000044408A3 Method of treating demyelinating inflammatory disease using ccr1 antagonists
12/14/2000WO2000044399A3 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000WO2000006187A9 Modulation of apoptosis
12/14/2000CA2751187A1 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid and derivatives thereof for treatment of hyperuricemia
12/14/2000CA2378735A1 Process for preparing 10,11-methanobenzosuberane derivatives
12/14/2000CA2377385A1 Methods and compositions for modulating cell proliferation and cell death
12/14/2000CA2376642A1 Recombinant nematode nicotinic receptor and uses
12/14/2000CA2376438A1 Identification of compounds that modify transcriptional responses to hypoxia
1 ... 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 ... 1151